Aims and Scope:
To promote innovative research in the biology, diagnosis, treatment, and prevention of cancer.
To highlight the development and clinical application of targeted therapies, including small molecules, monoclonal antibodies, immunotherapies, and gene therapies.
To bridge the gap between laboratory discoveries and clinical practice by encouraging translational research.
To foster interdisciplinary collaboration across oncology, pharmacology, molecular biology, genetics, and immunology.
To disseminate evidence-based practices and novel therapeutic approaches that enhance personalized cancer treatment.
The journal welcomes original research articles, comprehensive reviews, short communications, and
case reports in the following areas: Biomarkers for cancer diagnosis, prognosis, and treatment response
Development of novel targeted agents and drug delivery systems
Clinical trials and real-world studies on targeted therapies
Cancer genomics, epigenetics, and proteomics
Tumour microenvironment and immune-oncology
Resistance mechanisms to targeted treatments
Precision medicine and personalized therapeutic strategies
Combination therapies involving radiation, chemotherapy, and targeted drugs
Preclinical and translational oncology research
By providing a platform for high-quality scientific exchange, Oncological Research and Targeted Therapies seeks to advance our understanding of cancer and contribute to the development of more effective and individualized treatment options for patients worldwide.